FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295129629> ?p ?o ?g. }

• W4295129629 endingPage "175262" @default.
• W4295129629 startingPage "175262" @default.
• W4295129629 abstract "Among pulmonary arterial hypertension (PAH) patients, right ventricular (RV) functioning has been considered a major determining factor for cardiac capacity and survival. However, despite the recognition of the clinical importance for preserving RV functioning, no effective treatments are currently available for RV failure. This study aims to suggest one such possible treatment, through investigating the cardio-protective capabilities of the anti-oxidant, melatonin (Mel), for treating adverse RV remodeling in PAH, along with its underlying mechanisms. Arginine vasopressin induced neonatal rat cardiomyocyte hypertrophy in vitro; in vivo, PAH was induced in rats through intraperitoneal monocrotaline (MCT) injections, and Mel was administered intraperitoneally 24 h prior to MCT. Mel reduced rat cardiomyocyte hypertrophy and mitochondrial oxidative stress in vitro by activating the Mst1-Nrf2 pathway, which were all reversed upon siRNA knockdown of Mst1. Likewise, in vivo, Mel pre-treatment significantly ameliorated MCT-induced deterioration in cardiac function, RV hypertrophy, fibrosis and dilation. These beneficial effects were also associated with Mst1-Nrf2 pathway up regulation and its associated reduction in oxidative stress, as evidenced by the decrease in RV malondialdehyde content. Notably, results from Mel treatment were similar, or even superior, to those obtained from N-acetyl cysteine (NAC), which has already been-confirmed as an anti-oxidative treatment for PAH. By contrast, co-treatment with the Mst1 inhibitor XMU-MP-1 reversed all of those Mel-associated beneficial effects. Our findings thus identified Mel as a potent cardio-protective agent against the onset of maladaptive RV remodeling, through enhancement of the anti-oxidative response via Mst1-Nrf2 pathway activation." @default.
• W4295129629 created "2022-09-11" @default.
• W4295129629 creator A5003019825 @default.
• W4295129629 creator A5022499603 @default.
• W4295129629 creator A5042041170 @default.
• W4295129629 creator A5052547773 @default.
• W4295129629 creator A5055838753 @default.
• W4295129629 creator A5077015591 @default.
• W4295129629 creator A5077821599 @default.
• W4295129629 creator A5078024000 @default.
• W4295129629 creator A5084479642 @default.
• W4295129629 date "2022-10-01" @default.
• W4295129629 modified "2023-10-16" @default.
• W4295129629 title "Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension" @default.
• W4295129629 cites W1994316495 @default.
• W4295129629 cites W2001561654 @default.
• W4295129629 cites W2003279214 @default.
• W4295129629 cites W2025399018 @default.
• W4295129629 cites W2071319446 @default.
• W4295129629 cites W2088270875 @default.
• W4295129629 cites W2089097264 @default.
• W4295129629 cites W2112861506 @default.
• W4295129629 cites W2117339256 @default.
• W4295129629 cites W2129929756 @default.
• W4295129629 cites W2133993493 @default.
• W4295129629 cites W2134006584 @default.
• W4295129629 cites W2163302785 @default.
• W4295129629 cites W2166083608 @default.
• W4295129629 cites W2187630416 @default.
• W4295129629 cites W2203685013 @default.
• W4295129629 cites W2219189463 @default.
• W4295129629 cites W2402967421 @default.
• W4295129629 cites W2435647547 @default.
• W4295129629 cites W2479394673 @default.
• W4295129629 cites W2512544075 @default.
• W4295129629 cites W2527692420 @default.
• W4295129629 cites W2527913023 @default.
• W4295129629 cites W2529225907 @default.
• W4295129629 cites W2734481200 @default.
• W4295129629 cites W2743225886 @default.
• W4295129629 cites W2748185847 @default.
• W4295129629 cites W2757308637 @default.
• W4295129629 cites W2763242839 @default.
• W4295129629 cites W2784789637 @default.
• W4295129629 cites W2794636105 @default.
• W4295129629 cites W2796475084 @default.
• W4295129629 cites W2885384177 @default.
• W4295129629 cites W2886863229 @default.
• W4295129629 cites W2889422847 @default.
• W4295129629 cites W2911723925 @default.
• W4295129629 cites W2912278776 @default.
• W4295129629 cites W2963554762 @default.
• W4295129629 cites W2973492468 @default.
• W4295129629 cites W2974507609 @default.
• W4295129629 cites W2981396538 @default.
• W4295129629 cites W3008455966 @default.
• W4295129629 cites W3008666511 @default.
• W4295129629 cites W3013384801 @default.
• W4295129629 cites W3032631645 @default.
• W4295129629 cites W3044802484 @default.
• W4295129629 cites W3161651179 @default.
• W4295129629 cites W3195174905 @default.
• W4295129629 cites W4200466120 @default.
• W4295129629 cites W4206457055 @default.
• W4295129629 cites W4210811592 @default.
• W4295129629 doi "https://doi.org/10.1016/j.ejphar.2022.175262" @default.
• W4295129629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36100129" @default.
• W4295129629 hasPublicationYear "2022" @default.
• W4295129629 type Work @default.
• W4295129629 citedByCount "6" @default.
• W4295129629 countsByYear W42951296292022 @default.
• W4295129629 countsByYear W42951296292023 @default.
• W4295129629 crossrefType "journal-article" @default.
• W4295129629 hasAuthorship W4295129629A5003019825 @default.
• W4295129629 hasAuthorship W4295129629A5022499603 @default.
• W4295129629 hasAuthorship W4295129629A5042041170 @default.
• W4295129629 hasAuthorship W4295129629A5052547773 @default.
• W4295129629 hasAuthorship W4295129629A5055838753 @default.
• W4295129629 hasAuthorship W4295129629A5077015591 @default.
• W4295129629 hasAuthorship W4295129629A5077821599 @default.
• W4295129629 hasAuthorship W4295129629A5078024000 @default.
• W4295129629 hasAuthorship W4295129629A5084479642 @default.
• W4295129629 hasConcept C126322002 @default.
• W4295129629 hasConcept C134018914 @default.
• W4295129629 hasConcept C150903083 @default.
• W4295129629 hasConcept C164705383 @default.
• W4295129629 hasConcept C167414201 @default.
• W4295129629 hasConcept C207001950 @default.
• W4295129629 hasConcept C2776151105 @default.
• W4295129629 hasConcept C2778182776 @default.
• W4295129629 hasConcept C2778198053 @default.
• W4295129629 hasConcept C2779376020 @default.
• W4295129629 hasConcept C2780559512 @default.
• W4295129629 hasConcept C2780930700 @default.
• W4295129629 hasConcept C71924100 @default.
• W4295129629 hasConcept C86803240 @default.
• W4295129629 hasConcept C98274493 @default.
• W4295129629 hasConceptScore W4295129629C126322002 @default.

• next